tiprankstipranks
Trending News
More News >
4DMedical Ltd (AU:4DX)
:4DX
Australian Market

4DMedical Ltd (4DX) Stock Statistics & Valuation Metrics

Compare
32 Followers

Total Valuation

4DMedical Ltd has a market cap or net worth of AU$117.11M. The enterprise value is AU$187.92M.
Market CapAU$117.11M
Enterprise ValueAU$187.92M

Share Statistics

4DMedical Ltd has 450.42M shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding450.42M
Owened by Insiders0.84%
Owened by Instutions

Financial Efficiency

4DMedical Ltd’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per EmployeeAU$28,624.193
Profits Per Employee-AU$301,944.131
Employee Count145
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of 4DMedical Ltd is ―. 4DMedical Ltd’s PEG ratio is ―.
PE Ratio
PS Ratio
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow
PEG Ratio

Income Statement

In the last 12 months, 4DMedical Ltd had revenue of AU$4.15M and earned -AU$43.78M in profits. Earnings per share was -AU$0.11.
RevenueAU$4.15M
Gross Profit-AU$9.67M
Operating Income-AU$49.94M
Pretax Income-AU$46.54M
Net Income-AU$43.78M
EBITDA-50.22M
Earnings Per Share (EPS)-0.11

Cash Flow

In the last 12 months, operating cash flow was -AU$38.24M and capital expenditures -AU$741.40K, giving a free cash flow of -AU$38.98M billion.
Operating Cash Flow-AU$38.24M
Free Cash Flow-AU$38.98M
Free Cash Flow per Share-AU$0.09

Dividends & Yields

4DMedical Ltd pays an annual dividend of , resulting in a dividend yield of
Dividend Per Share
Dividend Yield
Payout Ratio
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.43
52-Week Price Change-55.93%
50-Day Moving Average0.39
200-Day Moving Average0.47
Relative Strength Index (RSI)19.61
Average Volume (3m)1.12M

Important Dates

4DMedical Ltd upcoming earnings date is Aug 28, 2025, After Close.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date

Financial Position

4DMedical Ltd as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, 4DMedical Ltd has paid -AU$2.76M in taxes.
Income Tax-AU$2.76M
Effective Tax Rate

Enterprise Valuation

4DMedical Ltd EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

4DMedical Ltd has AU$30.61M in cash and marketable securities with AU$5.12M in debt, giving a net cash position of -AU$25.49M billion.
Cash & Marketable SecuritiesAU$30.61M
Total DebtAU$5.12M
Net Cash-AU$25.49M
Net Cash Per Share-AU$0.06
Tangible Book Value Per Share

Margins

Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for 4DMedical Ltd is AU$0.85, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.85
Price Target Upside240.00%
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast471.29%
EPS Growth Forecast-4.58%

Scores

Smart Score5
AI Score32
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis